Research
Bristol-based EnsiliTech has raised its second oversubscribed funding round, securing £4.5m in seed funding to improve how life-saving medicines are stored and delivered worldwide. The company’s Ensilication process allows medicines to withstand temperatures up to 50°C. The funding will speed up proof-of-concept adoption for both existing and new biopharmaceuticals, expand capacity through new hires and [...]
By Muhunthan Thillai, CEO, Qureight Clinical trials are evolving rapidly as artificial intelligence transforms how we collect, analyse and interpret medical data. The integration of AI into clinical research promises more efficient trials, personalised interventions and accelerated development of life-saving treatments. However, realising these benefits requires establishing trust in complex AI systems among clinicians, regulators [...]
Optellum has announced the world’s first thorax CT foundation model built for precision lung care in real-world settings – an initiative aiming to revolutionise the early detection and management of lung diseases, with an initial focus on lung cancer. Unlike traditional AI systems built to deliver a narrow range of task-specific outcomes, Optellum’s foundation model [...]
A genetically modified pig lung transplanted into a brain-dead patient functioned for nine days, in what researchers say is a world first. The attempt marks the first pig lung transplant into a human, after limited progress with pig kidneys and hearts. Xenotransplantation – moving organs from animals to humans – may ease organ shortages, though [...]
A group of US researchers has developed a wearable device capable of accurately tracking chloride ion levels in sweat, which is essential for evaluating hydration status and health conditions like cystic fibrosis and more. Their sensor allows for real-time tracking of an exercising person’s sweat through a hydrogel-based design that allows the device to operate [...]
More than 1,000 bladder cancer patients a year can now access an NHS treatment shown in trials to double survival compared with standard chemotherapy. The combination therapy, available from today, has been described as "one of the most hopeful advances in decades" for people with the disease. Around 1,250 patients in England each year could [...]
ARC, the global healthcare transformation engine and innovation arm of the Sheba Medical Center, has announced a collaboration with Revealense, creators of a neurological-AI engine for analysing behavioural DNA in video footage. The collaboration establishes a joint venture focused on delivering an advanced neurological diagnostic solution. The joint solution will deliver precise, clinically validated diagnoses [...]
By Maja Schmidt Royal Commission Industrial Fellow at the University of Edinburgh and Neuranics Ischemic heart disease is the leading cause of premature death in the UK, and responsible for 66,000 deaths each year. Detecting heart rhythm abnormalities that indicate ischaemic heart disease outside controlled hospital environments remains a significant challenge. While [...]
An off-the-shelf cancer vaccine has shown potential in lowering the risk of pancreatic and colorectal cancer returning after surgery. The jab works by training the immune system to target and destroy cancer cells that may return after treatment, aiming to reduce relapse. Unlike personalised mRNA vaccines tailored to individual tumours, this non-personalised vaccine is already [...]
By Sanius Health Over the past five years we have seen an acceleration of new and innovative therapies in Sickle Cell Disease (SCD). Previously, this condition has experienced significant underinvestment, systemic inequity, and a lack of meaningful therapeutic options. This has been due to several reasons; not withstanding the fact that pharma companies have investors [...]
